RxDoctor Payments Data

Sydnee Hogue

Psychiatric/Mental Health · Moline, ILNPI 1548779291

Payments from drug & device makers

$2,761in general payments, 2019–2025

Across 31 payments — averaging $89.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$477
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$462
  • Otsuka America Pharmaceutical, Inc.$416
  • Idorsia Pharmaceuticals US Inc$289
  • Neurocrine Biosciences, Inc.$285
  • Alkermes, Inc.$218
  • plus $614 from 5 others

What the payments were for

  • Food & beverage$2,74399%
  • Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,761 in reported general payments places this provider in the 85th percentile of 922 psychiatric/mental health providers in Illinois.

See all psychiatric/mental health providers in Illinois

Medicare billing

Part B allowed, 2024
$18,985
Medicare patients
68
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl55$80,637
Wellbutrin XlBupropion Hcl12$30,953
ProzacFluoxetine Hcl12$14,691
LexaproEscitalopram Oxalate12$7,438
Aripiprazole115$4,786
Fluvoxamine Maleate36$4,053
Ziprasidone Hcl84$3,885
Duloxetine Hcl143$2,798
Oxcarbazepine56$2,784
Paliperidone ErPaliperidone26$2,710
Lisdexamfetamine Dimesylate12$2,511
Divalproex Sodium ErDivalproex Sodium58$2,490
Bupropion XlBupropion Hcl163$2,414
Hydroxyzine Hcl72$2,344
Risperidone112$2,270

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Lexapro$184$88,07567 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 922 psychiatric/mental health providers in Illinois.

Other psychiatric/mental health in Moline

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →